MedPath

Mifepristone and misoprostol compared with misoprostol alone for induction of labour of mid-trimester fetal demise

Phase 2
Completed
Conditions
Management of second trimester fetal demise
Mode of induction of labour
Reproductive Health and Childbirth - Other reproductive health and childbirth disorders
Registration Number
ACTRN12612000884808
Lead Sponsor
Emma Allanson
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
232
Inclusion Criteria

All women who are admitted to King Edward Memorial Hospital for Women for pregnancy interruption for fetal death in utero between 14 and 28 weeks gestation will be invited to participate in the study

Exclusion Criteria

Women with more than three previous caesarean sections
Women not able to understand English
Multi fetal gestations

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The efficacy of mifepristone priming in achieving pregnancy interruption in mid-trimester fetal demise. This will be determined by assessing the median time to delivery in both groups with the primary aim being a 30% reduction in time to delivery in group 1.[At delivery point]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath